Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 11;14(3):e0101024.
doi: 10.1128/mra.01010-24. Epub 2025 Feb 6.

Complete genome sequences of three Pseudomonas aeruginosa phages of the genus Phikmvvirus

Tracey L Peters  1 , Olga A Kirillina  2 , Martin O Georges  3 , Katie R Margulieux  2 , Kevin A Burke  2 , Nino Mzhavia  2 , Paphavee Lertsethtakarn  4 , Lillian A Musila  3 , Andrey A Filippov  2 , Mikeljon P Nikolich  2
Affiliations

Complete genome sequences of three Pseudomonas aeruginosa phages of the genus Phikmvvirus

Tracey L Peters et al. Microbiol Resour Announc. .

Abstract

We describe the genomes of three lytic Pseudomonas aeruginosa phages of the genus Phikmvvirus. The genomes of phages vB_Pae4841-AFR43, vB_Pae10145-KEN1, and vB_Pae9718-KEN10 consist of 43,426, 43,406, and 43,118 bp, with 62.4%, 62.3%, and 62.2% GC content, contain 63, 66, and 64 coding sequences, respectively, and no tRNA genes.

Keywords: Phikmvvirus; Pseudomonas aeruginosa; bacteriophages; complete genomes; therapeutic candidates.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig 1
Fig 1
Genome organization of three Phikmvvirus phages isolated in Thailand and Kenya. (A) AFR43; (B) KEN1; and (C) KEN10. The genome maps were prepared in Geneious v2024.0.5 and edited in Inkscape v1.3.2.
See this image and copyright information in PMC

References

    1. Sathe N, Beech P, Croft L, Suphioglu C, Kapat A, Athan E. 2023. Pseudomonas aeruginosa: infections and novel approaches to treatment “Knowing the enemy” the threat of Pseudomonas aeruginosa and exploring novel approaches to treatment. Infect Med (Beijing) 2:178–194. doi:10.1016/j.imj.2023.05.003 - DOI - PMC - PubMed
    1. Nawaz A, Khalid NA, Zafar S, Majid A, Shahzadi M, Saleem S, Shah AA, Badshah M, Khan S. 2024. Phage therapy as a revolutionary treatment for multidrug-resistant Pseudomonas aeruginosa infections: a narrative review. The Microbe 2:100030. doi:10.1016/j.microb.2023.100030 - DOI
    1. Santamaría-Corral G, Senhaji-Kacha A, Broncano-Lavado A, Esteban J, García-Quintanilla M. 2023. Bacteriophage-antibiotic combination therapy against Pseudomonas aeruginosa. Antibiotics (Basel) 12:1089. doi:10.3390/antibiotics12071089 - DOI - PMC - PubMed
    1. Mencke JL, He Y, Filippov AA, Nikolich MP, Belew AT, Fouts DE, McGann PT, Swierczewski BE, Getnet D, Ellison DW, Margulieux KR. 2022. Identification and characterization of vB_PreP_EPr2, a lytic bacteriophage of pan-drug resistant Providencia rettgeri. Viruses 14:708. doi:10.3390/v14040708 - DOI - PMC - PubMed
    1. Chen S, Zhou Y, Chen Y, Gu J. 2018. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34:i884–i890. doi:10.1093/bioinformatics/bty560 - DOI - PMC - PubMed

LinkOut - more resources